Nearly every SaaS product is either integrating AI or planning to do so. However, the term “AI” has become so broad that it’s often misunderstood, especially by non-technical founders. Words like ...
In another move designed to reduce the US' reliance on imported medicines, the FDA has launched a pilot of fast-track reviews for generics tested and made in domestic facilities. According to the ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...
Discover the 10 best Infrastructure as Code (IaC) tools for DevOps teams in 2025. Learn how these tools enhance automation, stability, and scalability in cloud environments. Improve your deployment ...
As a writer for Forbes Home since 2021, Emily specializes in writing about home warranties, solar installations, car transportation and moving companies. With a background in journalism and experience ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback